Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2011

01.04.2011 | Materno-fetal Medicine

Causes and consequences of 93 fetuses with cardiomegaly in a tertiary center in Thailand

verfasst von: Piyawadee Wuttikonsammakit, Boonchai Uerpairojkit, Somchai Tanawattanacharoen

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess etiology, perinatal mortality and associated factors of fetal cardiomegaly (FC).

Methods

A retrospective study of fetuses with cardiomegaly was conducted. Demographic data, ultrasonographic findings, and outcomes were collected and analyzed.

Results

Ninety-three fetuses were analyzed. The causes of FC were cardiac causes 49.5%, Bart’s hemoglobinopathies 28%, and non-Bart’s anemia 15%. Ascites, pericardial effusion, and hydrops were more prevalent in fetuses with anemia than those with cardiac abnormalities. The overall perinatal mortality was 69.9%. Although all Bart’s hydrops died, perinatal mortality of non-Bart’s anemia, and structural cardiac defect were 57.1 and 69.7%, respectively. Excluding Bart’s anemia, receiver-operating characteristic curve analysis demonstrated that cardiothoracic ratio of ≥0.58 best predictive for perinatal mortality. Earlier gestational age at diagnosis, skin edema, and chromosomal abnormality were associated with higher mortality.

Conclusions

Majority causes of FC were cardiac and anemic in origin. It carried high-perinatal mortality depending on the causes.
Literatur
1.
Zurück zum Zitat Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL (2006) A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 19:407–413PubMedCrossRef Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL (2006) A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med 19:407–413PubMedCrossRef
2.
Zurück zum Zitat Huhta JC (2004) Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 25:274–286PubMedCrossRef Huhta JC (2004) Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol 25:274–286PubMedCrossRef
3.
4.
Zurück zum Zitat Kleinman CS, Donnerstein RL, DeVore GR, Jaffe CC, Lynch DC, Berkowitz RL et al (1982) Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med 306:568–575PubMedCrossRef Kleinman CS, Donnerstein RL, DeVore GR, Jaffe CC, Lynch DC, Berkowitz RL et al (1982) Fetal echocardiography for evaluation of in utero congestive heart failure. N Engl J Med 306:568–575PubMedCrossRef
5.
Zurück zum Zitat Respondek M, Kaczmarek P, Pertynski T (1996) Fetal echocardiography guidelines to predict survival of fetuses with ascites. Ultrasound Obstet Gynecol 7:256–261PubMedCrossRef Respondek M, Kaczmarek P, Pertynski T (1996) Fetal echocardiography guidelines to predict survival of fetuses with ascites. Ultrasound Obstet Gynecol 7:256–261PubMedCrossRef
6.
Zurück zum Zitat Chaoui R, Bollmann R, Goldner B, Heling KS, Tennstedt C (1994) Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther 9:92–104PubMedCrossRef Chaoui R, Bollmann R, Goldner B, Heling KS, Tennstedt C (1994) Fetal cardiomegaly: echocardiographic findings and outcome in 19 cases. Fetal Diagn Ther 9:92–104PubMedCrossRef
7.
Zurück zum Zitat Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15PubMedCrossRef Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15PubMedCrossRef
8.
Zurück zum Zitat Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917PubMedCrossRef Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917PubMedCrossRef
9.
Zurück zum Zitat Leung KY, Liao C, Li QM et al (2006) A new strategy for prenatal diagnosis of homozygous alpha(α0)-thalassemia. Ultrasound Obstet Gynecol 28:173–177PubMedCrossRef Leung KY, Liao C, Li QM et al (2006) A new strategy for prenatal diagnosis of homozygous alpha(α0)-thalassemia. Ultrasound Obstet Gynecol 28:173–177PubMedCrossRef
10.
Zurück zum Zitat von Kaisenberg CS, Jonat W (2001) Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 18:280–288CrossRef von Kaisenberg CS, Jonat W (2001) Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 18:280–288CrossRef
11.
Zurück zum Zitat Oyer CE, Ongcapin EH, Ni J, Bowles NE, Towbin JA (2000) Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction. Hum Pathol 31:1433–1435PubMedCrossRef Oyer CE, Ongcapin EH, Ni J, Bowles NE, Towbin JA (2000) Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction. Hum Pathol 31:1433–1435PubMedCrossRef
12.
Zurück zum Zitat Pedra SRFF, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R et al (2002) Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106:585–591PubMedCrossRef Pedra SRFF, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R et al (2002) Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106:585–591PubMedCrossRef
13.
Zurück zum Zitat Sivasankaran S, Sharland GK, Simpson JM (2005) Dilated cardiomyopathy presenting during fetal life. Cardiol Young 15:409–416PubMedCrossRef Sivasankaran S, Sharland GK, Simpson JM (2005) Dilated cardiomyopathy presenting during fetal life. Cardiol Young 15:409–416PubMedCrossRef
14.
Zurück zum Zitat Yinon Y, Yagel S, Hegesh J, Weisz B, Mazaki-Tovi S, Lipitz S et al (2007) Fetal cardiomyopathy-in utero evaluation and clinical significance. Prenat Diagn 27:23–28PubMedCrossRef Yinon Y, Yagel S, Hegesh J, Weisz B, Mazaki-Tovi S, Lipitz S et al (2007) Fetal cardiomyopathy-in utero evaluation and clinical significance. Prenat Diagn 27:23–28PubMedCrossRef
15.
Zurück zum Zitat Mari G, Adrignolo A, Abuhamad AZ, Pirhonen J, Jones DC, Ludomirsky A, Copel JA (1995) Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 5:400–405PubMedCrossRef Mari G, Adrignolo A, Abuhamad AZ, Pirhonen J, Jones DC, Ludomirsky A, Copel JA (1995) Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet Gynecol 5:400–405PubMedCrossRef
16.
Zurück zum Zitat Forestier F, Daffos F, Catherine N, Renard M, Andreux JP (1991) Developmental hematopoiesis in normal human fetal blood. Blood 77:2360–2363PubMed Forestier F, Daffos F, Catherine N, Renard M, Andreux JP (1991) Developmental hematopoiesis in normal human fetal blood. Blood 77:2360–2363PubMed
17.
Zurück zum Zitat Nakayama R, Yamada D, Steinmiller V, Hsia E, Hale RW (1986) Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet Gynecol 67:176–180PubMedCrossRef Nakayama R, Yamada D, Steinmiller V, Hsia E, Hale RW (1986) Hydrops fetalis secondary to Bart hemoglobinopathy. Obstet Gynecol 67:176–180PubMedCrossRef
18.
Zurück zum Zitat Bolton-Maggs PHB, Stevens RJ, Dodd NJ, Lamont G, Tittensor P, King MJ (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. BJH 126:455–474CrossRef Bolton-Maggs PHB, Stevens RJ, Dodd NJ, Lamont G, Tittensor P, King MJ (2004) Guidelines for the diagnosis and management of hereditary spherocytosis. BJH 126:455–474CrossRef
19.
Zurück zum Zitat Elchalal U, Ezra Y, Levi Y, Bar-oz B, Yanai N, Intrator O et al (2000) Sonographically thick placenta: a marker for increased perinatal risk—a prospective cross-sectional study. Placenta 21:268–272PubMedCrossRef Elchalal U, Ezra Y, Levi Y, Bar-oz B, Yanai N, Intrator O et al (2000) Sonographically thick placenta: a marker for increased perinatal risk—a prospective cross-sectional study. Placenta 21:268–272PubMedCrossRef
20.
Zurück zum Zitat Fyler DC, Buckley LP, Hellenbrand WE, Cohn HE (1980) Report of the New England Regional Infant Cardiac Program. Pediatrics 65:375–461 Fyler DC, Buckley LP, Hellenbrand WE, Cohn HE (1980) Report of the New England Regional Infant Cardiac Program. Pediatrics 65:375–461
21.
Zurück zum Zitat Gandhi JA, Zhang XY, Maidman JE (1995) Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol 173:1132–1136PubMedCrossRef Gandhi JA, Zhang XY, Maidman JE (1995) Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol 173:1132–1136PubMedCrossRef
22.
Zurück zum Zitat Kush ML, Weiner CP, Harman CR, Baschat AA (2003) Lethal progression of a fetal intracranial arteriovenous malformation. J Ultrasound Med 22:645–648PubMed Kush ML, Weiner CP, Harman CR, Baschat AA (2003) Lethal progression of a fetal intracranial arteriovenous malformation. J Ultrasound Med 22:645–648PubMed
23.
Zurück zum Zitat Skoll MA, Sharland GK, Allan LD (1991) Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol 1:309–312PubMedCrossRef Skoll MA, Sharland GK, Allan LD (1991) Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol 1:309–312PubMedCrossRef
24.
Zurück zum Zitat Tennstedt C, Chaoui R, Korner H, Dietel M (1999) Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 82:34–39PubMed Tennstedt C, Chaoui R, Korner H, Dietel M (1999) Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 82:34–39PubMed
Metadaten
Titel
Causes and consequences of 93 fetuses with cardiomegaly in a tertiary center in Thailand
verfasst von
Piyawadee Wuttikonsammakit
Boonchai Uerpairojkit
Somchai Tanawattanacharoen
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1426-0

Weitere Artikel der Ausgabe 4/2011

Archives of Gynecology and Obstetrics 4/2011 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.